GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovis Corp (NYSE:ENOV) » Definitions » Cyclically Adjusted Price-to-FCF

Enovis (Enovis) Cyclically Adjusted Price-to-FCF : 14.21 (As of Apr. 27, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Enovis Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), Enovis's current share price is $55.26. Enovis's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $3.89. Enovis's Cyclically Adjusted Price-to-FCF for today is 14.21.

The historical rank and industry rank for Enovis's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

ENOV' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 6.25   Med: 13.97   Max: 27.01
Current: 14.16

During the past years, Enovis's highest Cyclically Adjusted Price-to-FCF was 27.01. The lowest was 6.25. And the median was 13.97.

ENOV's Cyclically Adjusted Price-to-FCF is ranked better than
82.28% of 1016 companies
in the Industrial Products industry
Industry Median: 32.505 vs ENOV: 14.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Enovis's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $0.741. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $3.89 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Enovis Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Enovis's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enovis Cyclically Adjusted Price-to-FCF Chart

Enovis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.87 14.43 15.76 11.27 14.39

Enovis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.27 10.88 13.74 11.92 14.39

Competitive Comparison of Enovis's Cyclically Adjusted Price-to-FCF

For the Specialty Industrial Machinery subindustry, Enovis's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enovis's Cyclically Adjusted Price-to-FCF Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Enovis's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Enovis's Cyclically Adjusted Price-to-FCF falls into.



Enovis Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Enovis's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=55.26/3.89
=14.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enovis's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Enovis's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.741/129.4194*129.4194
=0.741

Current CPI (Dec. 2023) = 129.4194.

Enovis Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -2.094 99.695 -2.718
201406 1.781 100.560 2.292
201409 3.532 100.428 4.552
201412 3.801 99.070 4.965
201503 -0.317 99.621 -0.412
201506 1.479 100.684 1.901
201509 1.700 100.392 2.192
201512 2.769 99.792 3.591
201603 0.003 100.470 0.004
201606 0.751 101.688 0.956
201609 0.713 101.861 0.906
201612 3.003 101.863 3.815
201703 0.695 102.862 0.874
201706 1.043 103.349 1.306
201709 0.148 104.136 0.184
201712 1.742 104.011 2.168
201803 -0.333 105.290 -0.409
201806 0.552 106.317 0.672
201809 1.310 106.507 1.592
201812 2.449 105.998 2.990
201903 -2.168 107.251 -2.616
201906 0.945 108.070 1.132
201909 0.414 108.329 0.495
201912 0.859 108.420 1.025
202003 0.533 108.902 0.633
202006 0.388 108.767 0.462
202009 1.059 109.815 1.248
202012 2.095 109.897 2.467
202103 1.266 111.754 1.466
202106 1.136 114.631 1.283
202109 1.286 115.734 1.438
202112 1.220 117.630 1.342
202203 -0.715 121.301 -0.763
202206 -0.891 125.017 -0.922
202209 -0.027 125.227 -0.028
202212 -1.342 125.222 -1.387
202303 -0.423 127.348 -0.430
202306 -0.160 128.729 -0.161
202309 0.073 129.860 0.073
202312 0.741 129.419 0.741

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Enovis  (NYSE:ENOV) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Enovis Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Enovis's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Enovis (Enovis) Business Description

Industry
Traded in Other Exchanges
Address
2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy.. The company conducts its operations through two operating segments: Prevention & Recovery ("P&R") and Reconstructive ("Recon"). It generates majority revenue form Prevention & Recovery segment.
Executives
John Kleckner officer: Principal Accounting Officer 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Berry Phillip Benjamin (ben) officer: SVP, Chief Financial Officer 2711 CENTERVILLE ROAD SUITE 400, WILMINGTON DE 19808
Rajiv Vinnakota director 8730 STONY POINT PARKWAY, SUITE 150, RICHMOND VA 23235
A Clayton Perfall director
Brady Shirley officer: EVP, Colfax, Pres. & CEO, DJO 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Patricia A Lang officer: SVP, Chief HR Officer C/O DIEBOLD NIXDORF, INCORPORATED, 5995 MAYFAIR ROAD, NORTH CANTON OH 44720
Bradley J Tandy officer: SVP, General Counsel P.O. BOX 587, 56 E. BELL DRIVE, WARSAW IN 46580
Daniel A Pryor officer: SVP??Strategy & Business Deve. DANAHER CORP, 2099 PENNSYLVANIA AVE NW 12TH FL, WASHINGTON DC 20006
Matthew L. Trerotola director, officer: President & CEO 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Christopher M Hix officer: SVP, Chief Financial Officer 2160 SATELLITE BLVD., SUITE 200, DULUTH GA 30097
Barbara W. Bodem director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Christine Ortiz director 1200 ABERNATHY ROAD, NE, SUITE 1200, ATLANTA GA 30328
Angela S Lalor director 3M CENTER, BLDG. 0220-09-E-02, ST PAUL MN 55144 1000
Shyam Kambeyanda officer: ESAB President and SVP, Colfax 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Douglas J. Pitts officer: Controller, PAO 100 MATSONFORD ROAD, RADNOR PA 19087